Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Egg Supplementation

Research Leaders

7 sponsors active, led by Protara Therapeutics Inc.

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2/3 (1)

Trial Status

Completed1
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06910943Phase 2/3RecruitingPrimary

Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

NCT04036552UnknownPrimary

The Associations Between Dietary Choline, Genetics and Anxiety/Depression

NCT02446873Not ApplicableCompletedPrimary

Cracking the Egg Potential: Improving Young Child Nutrition in Ecuador

Showing all 3 trials

Research Network

Common Treatments

  • Egg Supplementation1
  • Choline Chloride1

Active Sponsors

  • Protara Therapeutics Inc.1
  • Pan American Health Organization1
  • Protara Therapeutics1
  • Universidad San Francisco de Quito1
  • St Mary's University College1

Top Investigators

Related Conditions

  • Amino Acids Deficiency1
  • Depression1
  • Anxiety1
  • Liver Injury1
  • Vitamin B12 Deficiency1

Activity Timeline